Abstract: ABSTRACT TRIAMINO PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS AND METHODS THEREOF The present disclosure provides triamino pyrimidine compounds of Formula (I), its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, 5 polymorphs, or pharmaceutically active derivatives thereof as CDK7 inhibitors. The present disclosure also provides pharmaceutical composition comprising said compounds. The present disclosure further provides process of preparing said compounds and methods thereof.
DESC:TRIAMINO PYRIMIDINE COMPOUNDS AS CDK7 INHIBITORS AND METHODS THEREOF ,CLAIMS:AS ATTACHED
| # | Name | Date |
|---|---|---|
| 1 | 202441014181-STATEMENT OF UNDERTAKING (FORM 3) [27-02-2024(online)].pdf | 2024-02-27 |
| 2 | 202441014181-PROVISIONAL SPECIFICATION [27-02-2024(online)].pdf | 2024-02-27 |
| 3 | 202441014181-FORM 1 [27-02-2024(online)].pdf | 2024-02-27 |
| 4 | 202441014181-FORM-26 [01-05-2024(online)].pdf | 2024-05-01 |
| 5 | 202441014181-Proof of Right [26-07-2024(online)].pdf | 2024-07-26 |
| 6 | 202441014181-DRAWING [27-02-2025(online)].pdf | 2025-02-27 |
| 7 | 202441014181-CORRESPONDENCE-OTHERS [27-02-2025(online)].pdf | 2025-02-27 |
| 8 | 202441014181-COMPLETE SPECIFICATION [27-02-2025(online)].pdf | 2025-02-27 |
| 9 | 202441014181-Request Letter-Correspondence [20-03-2025(online)].pdf | 2025-03-20 |
| 10 | 202441014181-Power of Attorney [20-03-2025(online)].pdf | 2025-03-20 |
| 11 | 202441014181-Form 1 (Submitted on date of filing) [20-03-2025(online)].pdf | 2025-03-20 |
| 12 | 202441014181-Covering Letter [20-03-2025(online)].pdf | 2025-03-20 |
| 13 | 202441014181-CERTIFIED COPIES TRANSMISSION TO IB [20-03-2025(online)].pdf | 2025-03-20 |